Free Newsletter
Register for our Free Newsletters
Newsletter
Zones
Analysis, Inspection and Laboratory
LeftNav
Assisted/Independent Living
LeftNav
Clinical and Nursing Equipment
LeftNav
Design and Manufacture of Medical Equipment
LeftNav
Diagnostics Equipment, Monitoring and Test
LeftNav
Education, Training and Professional Services
LeftNav
Health Education and Patient Management
LeftNav
Health Estates Management
LeftNav
Healthcare Support and Information Services
LeftNav
Hygiene and Infection Control
LeftNav
IT and Communications in Healthcare
LeftNav
Materials
LeftNav
Medical Device Technology
LeftNav
Research and Development
LeftNav
Safety and Security
LeftNav
View All
Other Carouselweb publications
Carousel Web
Defense File
New Materials
Pro Health Zone
Pro Health Zone
Pro Security Zone
Web Lec
Pro Engineering Zone
 
 
News

Medical sector promises growth potential for food ingredient companies

Kalorama Information : 05 December, 2007  (New Product)
Kalorama Information believes that growing price competition from low-cost manufacturers is forcing ingredient companies to search for new ways to sustain profitable growth and the market research company predicts growth is likely to come from the sale of products or byproducts to pharmaceutical, medical foods, or biomedical device companies.
A new report published by Kalorama Information and entitled 'Healthcare Opportunities for Food Ingredient Manufacturers' estimates that the market could potentially be worth $1 billion.

Thousands of bioactive phytochemicals have potential or established pharmaceutical or medicinal applications. Food-grade pectin, used as a thickening agent and stabilizer in food, tops the industry’s list of ingredients most likely to succeed in healthcare.

Useful for such applications as drug delivery, gene repair, and tissue repair, pectin offers food ingredient manufacturers as much as $890 million in sales to the healthcare industry.

Glycomacropeptide, a whey component that is released during the manufacturer of cheese, has been shown to stimulate the body’s synthesis and release of cholesystokinen. This compound plays a role in the regulation of digestion and appetite suppression, providing yet another $65.6 million market in the healthcare industry.

“There are a variety of market opportunities in the healthcare sector, either in drugs, medical foods, or medical devices,” said Steven Heffner, publisher of Kalorama Information. “The cost-effective discovery and recovery of novel ingredients with improved properties from food processing streams depends on next generation analysis, isolation, and separation technologies. Food ingredient manufacturers will have to turn to science and technological advances to add value to their primary, byproduct, and waste streams.”

'Healthcare Opportunities for Food Ingredient Manufacturers' analyses the current and potential healthcare-related markets for some traditional food ingredients and materials, including glycomacropeptide, lactoferrin, dairy bioactives, serum protein concentrate, shell eggs, peanut skins, pectin, xanthan gum, and hydrogels. The report reviews the nature and direction of research, analyses market opportunities for these materials in the pharmaceutical, medical foods, and biomedical device sectors, and provides an outlook on future markets.
Bookmark and Share
 
Home I Editor's Blog I News by Zone I News by Date I News by Category I Special Reports I Directory I Events I Advertise I Submit Your News I About Us I Guides
 
   © 2012 ProHealthServiceZone.com
Netgains Logo